Statins induce apoptosis through inhibition of Ras signaling pathways and enhancement of Bim and p27 expression in human hematopoietic tumor cells
Open Access
- 9 October 2017
- journal article
- research article
- Published by IOS Press in Tumor Biology
- Vol. 39 (10)
- https://doi.org/10.1177/1010428317734947
Abstract
Recently, statins have been demonstrated to improve cancer-related mortality or prognosis in patients of various cancers. However, the details of the apoptosis-inducing mechanisms remain unknown. This study showed that the induction of apoptosis by statins in hematopoietic tumor cells is mediated by mitochondrial apoptotic signaling pathways, which are activated by the suppression of mevalonate or geranylgeranyl pyrophosphate biosynthesis. In addition, statins decreased the levels of phosphorylated extracellular signal–regulated kinase 1/2 and mammalian target of rapamycin through suppressing Ras prenylation. Furthermore, inhibition of extracellular signal–regulated kinase 1/2 and mammalian target of rapamycin by statins induced Bim expression via inhibition of Bim phosphorylation and ubiquitination and cell-cycle arrest at G1 phase via enhancement of p27 expression. Moreover, combined treatment of U0126, a mitogen-activated protein kinase kinase 1/2 inhibitor, and rapamycin, a mammalian target of rapamycin inhibitor, induced Bim and p27 expressions. The present results suggested that statins induce apoptosis by decreasing the mitochondrial transmembrane potential, increasing the activation of caspase-9 and caspase-3, enhancing Bim expression, and inducing cell-cycle arrest at G1 phase through inhibition of Ras/extracellular signal–regulated kinase and Ras/mammalian target of rapamycin pathways. Therefore, our findings support the use of statins as potential anticancer agents or concomitant drugs of adjuvant therapy.Keywords
This publication has 33 references indexed in Scilit:
- Statin use after esophageal cancer diagnosis and survival: A population based cohort studyCancer Epidemiology, 2017
- Statin use and risk of multiple myeloma: An analysis from the cancer research networkInternational Journal of Cancer, 2017
- The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysisBreast Cancer Research and Treatment, 2017
- Statin use and survival outcomes in endocrine-related gynecologic cancers: A systematic review and meta-analysisOncotarget, 2017
- Statin use and all-cause and cancer mortality: BioBank Japan cohortJournal of Epidemiology, 2017
- Statin improves survival in patients with EGFR-TKI lung cancer: A nationwide population-based studyPLOS ONE, 2017
- Statins for Prevention of Cardiovascular Disease in AdultsJAMA, 2016
- In vitro and in vivo downregulation of the ATP binding cassette transporter B1 by the HMG-CoA reductase inhibitor simvastatinNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2015
- The origin of the statinsAtherosclerosis Supplements, 2004
- HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosisLeukemia, 2002